Treating Insomnia During Pregnancy: Is Trazodone Safe?
More study is needed regarding the safety of trazodone for the treatment of insomnia during pregnancy.
Essential Reads: Modafinil and Armodafinil During Pregnancy Associated with Increased Risk of Malformations
Modafinil (brand name Provigil) and armodafinil (Nuvigil) are wake-promoting agents used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea. They are also used in other settings, often in [...]
Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications
Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.
New Study Investigates the Impact of Prenatal SSRI Exposure on Brain Structure in Older Children
Maternal SSRI use during pregnancy may be associated with altered brain development in children; however, this study cannot fully rule out contributions of confounding genetic and enviromental factors.
Is Remeron (Mirtazapine) Safe to Use During Pregnancy? New Data
This study provides reassuring data on the use of mirtazapine during pregnancy, demonstrating no association between exposure and risk of major malformations or pregnancy loss.
Mandatory Signs Describing the Risks of Cannabis Use During Pregnancy: Do They Work?
Mandatory warning sign policies were not associated with reduced cannabis use during pregnancy, nor did they shift opinions regarding risk among those using cannabis prior to pregnancy.
New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
More Data on Pregnancy Outcomes Associated with Lithium Use During Pregnancy
Lithium use during pregnancy was associated with an increased risk of preterm birth and large for gestational age infants.
New Research from the CWMH: More Data on the Reproductive Safety of Lurasidone and Quetiapine
New findings from the National Pregnancy Registry for Atypical Antipsychotics provide reassuring data regarding the safety of prenatal exposure to lurasidone and quetiapine in a sample of well-characterized participants.
What Has a Greater Effect on Children’s Behavior: Prenatal Exposure to Antidepressants or Maternal Depression?
Maternal depression during the third trimester, not prenatal SSRI exposure, was associated with higher levels of internalizing and anxiety behaviors in children from 3 to 12 years of age.